This story was in today's Boston Globe, but since it is from Stat News (a new science research news site owned by John Henry, who also owns the Globe), it may be in other newspapers also.
In summary the story is about
lung cancer but also says about
2/3 of the way through
"Although extensive testing has been done only in lung cancer, CimaVax also has the potential to be used against other EGF-dependent solid tumors, including some forms of breast, prostate, colon, and head and neck cancer..."
Clinical trials done in Cuba, others underway in Europe and Maylasia for CimaVax - a vaccine. Roswell Park Cancer Institute, Buffalo is applying to FDA for a clinical trial.
/www.statnews.com/2016/08/05/lung-cancer-cuba-biotech/Jim